0001209191-23-012123.txt : 20230223
0001209191-23-012123.hdr.sgml : 20230223
20230223145126
ACCESSION NUMBER: 0001209191-23-012123
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230210
FILED AS OF DATE: 20230223
DATE AS OF CHANGE: 20230223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HU ANGELA
CENTRAL INDEX KEY: 0001966685
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37347
FILM NUMBER: 23659053
MAIL ADDRESS:
STREET 1: 5217 WINNEBAGO LN
CITY: AUSTIN
STATE: TX
ZIP: 78744
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: XBiotech Inc.
CENTRAL INDEX KEY: 0001626878
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5217 WINNEBAGO LANE
CITY: AUSTIN
STATE: TX
ZIP: 78744
BUSINESS PHONE: 512-386-2900
MAIL ADDRESS:
STREET 1: 5217 WINNEBAGO LANE
CITY: AUSTIN
STATE: TX
ZIP: 78744
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-02-10
0
0001626878
XBiotech Inc.
XBIT
0001966685
HU ANGELA
5217 WINNEBAGO LN
AUSTIN
TX
78744
0
1
0
0
Principle Financial Officer
Common Stock
25500
D
Employee Stock Option (right to buy)
19.00
2016-04-01
2025-04-01
Common Stock
4500
D
Employee Stock Option (right to buy)
5.26
2020-01-04
2029-01-03
Common Stock
5000
D
Employee Stock Option (right to buy)
10.36
2020-11-06
2029-11-05
Common Stock
10000
D
Employee Stock Option (right to buy)
12.67
2022-11-19
2031-11-18
Common Stock
10000
D
Employee Stock Option (right to buy)
3.84
2023-08-10
2033-02-09
Common Stock
30000
D
On April 1, 2015 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in four equal portions in four years commencing as of April 1, 2016, with an expiry of ten years from the Grant Date.
On January 4, 2019 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal portions in two years commencing as of January 4, 2020, with an expiry of ten years from the Grant Date.
On November 6, 2019 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal portions in two years commencing as of November 6, 2020, with an expiry of ten years from the Grant Date.
On November 19, 2021 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal portions in two years commencing as of November 19, 2022, with an expiry of ten years from the Grant Date.
On February 10, 2023 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in four equal portions in two years commencing as of August 10, 2023, with an expiry of ten years from the Grant Date.
/s/ Angela Hu
2023-02-23